Role of high-dose interleukin-2 for melanoma in the age of cellular therapy.
Saved in:
| Title: | Role of high-dose interleukin-2 for melanoma in the age of cellular therapy. |
|---|---|
| Authors: | Buchbinder E; Dana-Farber Cancer Institute, Boston, Massachusetts, USA elizabeth_buchbinder@dfci.harvard.edu., Lotze MT; University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Margolin KA; Medical Oncology, City of Hope National Medical Center, Duarte, California, USA., Amaria R; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sarnaik A; H Lee Moffitt Canc Ctr, Tampa, Florida, USA., Seery V; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Eroglu Z; Moffitt Cancer Center, Tampa, Florida, USA., Khaddour K; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Betof Warner A; Stanford University School of Medicine, Stanford, California, USA., Kluger HM; Medical Oncology, Yale University School of Medicine, New Haven, Connecticut, USA., Sznol M; Yale Cancer Center, Yale University, New Haven, Connecticut, USA., Atkins MB; Oncology, Georgetown University, Washington, District of Columbia, USA., Mcdermott DF; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Silk AW; Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA. |
| Source: | Journal for immunotherapy of cancer [J Immunother Cancer] 2025 May 30; Vol. 13 (5). Date of Electronic Publication: 2025 May 30. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40447314 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Role of high-dose interleukin-2 for melanoma in the age of cellular therapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Buchbinder+E%22">Buchbinder E</searchLink>; Dana-Farber Cancer Institute, Boston, Massachusetts, USA elizabeth&#95;buchbinder@dfci.harvard.edu.<br /><searchLink fieldCode="AU" term="%22Lotze+MT%22">Lotze MT</searchLink>; University of Pittsburgh, Pittsburgh, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Margolin+KA%22">Margolin KA</searchLink>; Medical Oncology, City of Hope National Medical Center, Duarte, California, USA.<br /><searchLink fieldCode="AU" term="%22Amaria+R%22">Amaria R</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Sarnaik+A%22">Sarnaik A</searchLink>; H Lee Moffitt Canc Ctr, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Seery+V%22">Seery V</searchLink>; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Eroglu+Z%22">Eroglu Z</searchLink>; Moffitt Cancer Center, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Khaddour+K%22">Khaddour K</searchLink>; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Betof+Warner+A%22">Betof Warner A</searchLink>; Stanford University School of Medicine, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Kluger+HM%22">Kluger HM</searchLink>; Medical Oncology, Yale University School of Medicine, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Sznol+M%22">Sznol M</searchLink>; Yale Cancer Center, Yale University, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Atkins+MB%22">Atkins MB</searchLink>; Oncology, Georgetown University, Washington, District of Columbia, USA.<br /><searchLink fieldCode="AU" term="%22Mcdermott+DF%22">Mcdermott DF</searchLink>; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Silk+AW%22">Silk AW</searchLink>; Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2025 May 30; Vol. 13 (5). <i>Date of Electronic Publication: </i>2025 May 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40447314 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1136/jitc-2024-011119 Languages: – Code: eng Text: English Titles: – TitleFull: Role of high-dose interleukin-2 for melanoma in the age of cellular therapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Buchbinder E – PersonEntity: Name: NameFull: Lotze MT – PersonEntity: Name: NameFull: Margolin KA – PersonEntity: Name: NameFull: Amaria R – PersonEntity: Name: NameFull: Sarnaik A – PersonEntity: Name: NameFull: Seery V – PersonEntity: Name: NameFull: Eroglu Z – PersonEntity: Name: NameFull: Khaddour K – PersonEntity: Name: NameFull: Betof Warner A – PersonEntity: Name: NameFull: Kluger HM – PersonEntity: Name: NameFull: Sznol M – PersonEntity: Name: NameFull: Atkins MB – PersonEntity: Name: NameFull: Mcdermott DF – PersonEntity: Name: NameFull: Silk AW IsPartOfRelationships: – BibEntity: Dates: – D: 30 M: 05 Text: 2025 May 30 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2051-1426 Numbering: – Type: volume Value: 13 – Type: issue Value: 5 Titles: – TitleFull: Journal for immunotherapy of cancer Type: main |
| ResultId | 1 |